Janus Henderson Group
BSTC

Janus Henderson Group’s BioSpecifics Technologies Corp. BSTC Stock Holding History

Janus Henderson Group’s Portfolio BSTC Stock Details BSTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-301,321
Closed -$15.9M – 1458
2020
Q3 		$15.9M Buy
301,321
+2,412
+0.8% +$149K 0.01% 758
2020
Q2 		$18.3M Buy
298,909
+21,722
+8% +$1.26M 0.01% 710
2020
Q1 		$15.7M Buy
277,187
+272,928
+6,408% +$15.6M 0.01% 727
2019
Q4 		$243K Buy
4,259
+226
+6% +$12K ﹤0.01% 1375
2019
Q3 		$216K Buy
4,033
+564
+16% +$32.8K ﹤0.01% 1374
2019
Q2 		$207K Sell
3,469
-141
-4% -$8.87K ﹤0.01% 1351
2019
Q1 		$225K Sell
3,610
-415
-10% -$27.5K ﹤0.01% 1319
2018
Q4 		$244K Buy
4,025
+179
+5% +$10.7K ﹤0.01% 1294
2018
Q3 		$225K Buy
+3,846
New +$196K ﹤0.01% 1421

Other funds holding BSTC

UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Janus Henderson Group's BSTC Position: Q4 2020 in Review

Janus Henderson Group sold out of BioSpecifics Technologies Corp. (BSTC) in Q4 2020, closing a stake of 301,321 shares — an estimated $15.9M sold.

Janus Henderson Group first reported a position in BSTC in Q3 2018 and held it in 9 quarters. The position peaked at $18.3M in Q2 2020. 1 fund tracked by Wall St. Rank holds BSTC as of Q4 2020.

  • Janus Henderson Group reported no remaining BioSpecifics Technologies Corp. position as of Q4 2020 after selling out during the quarter.
  • Janus Henderson Group sold 301,321 BioSpecifics Technologies Corp. shares in Q4 2020, an estimated $15.9M.
  • Janus Henderson Group first reported a position in BioSpecifics Technologies Corp. in Q3 2018 and held it in 9 quarters.
  • Janus Henderson Group's BioSpecifics Technologies Corp. position peaked at $18.3M in Q2 2020.
  • 1 fund tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q4 2020.

Based on Janus Henderson Group's 13F filing for Q4 2020, filed 16 Feb 2021.